CRISPR/cas9 endonuclease-mediated genome editing is used to create a tyrosine to alanine substitution at position 142 (Y142A, TAC to GCT) and a G to A substitution two bases downstream (creating an AflII target site). The mutation disrupts phosphorylation of Y142. (J:321790)